These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 33918477)
1. The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer. Werner H; Sarfstein R; Laron Z Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33918477 [TBL] [Abstract][Full Text] [Related]
2. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells. Sarfstein R; Nagaraj K; LeRoith D; Werner H Cells; 2019 Nov; 8(12):. PubMed ID: 31771180 [TBL] [Abstract][Full Text] [Related]
3. Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction. Sarfstein R; Werner H Endocrinology; 2013 May; 154(5):1672-9. PubMed ID: 23507573 [TBL] [Abstract][Full Text] [Related]
4. The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities. Werner H Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834331 [TBL] [Abstract][Full Text] [Related]
5. Identification of nucleolar protein NOM1 as a novel nuclear IGF1R-interacting protein. Solomon-Zemler R; Pozniak Y; Geiger T; Werner H Mol Genet Metab; 2019 Mar; 126(3):259-265. PubMed ID: 30639046 [TBL] [Abstract][Full Text] [Related]
6. Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns. Sarfstein R; Yeheskel A; Sinai-Livne T; Pasmanik-Chor M; Werner H Front Endocrinol (Lausanne); 2020; 11():435. PubMed ID: 32733384 [TBL] [Abstract][Full Text] [Related]
7. Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors. Chen J; Nagle AM; Wang YF; Boone DN; Lee AV J Biol Chem; 2018 Mar; 293(10):3700-3709. PubMed ID: 29330302 [TBL] [Abstract][Full Text] [Related]
8. Insulin receptor and IGF1R are not required for oocyte growth, differentiation, and maturation in mice. Pitetti JL; Torre D; Conne B; Papaioannou MD; Cederroth CR; Xuan S; Kahn R; Parada LF; Vassalli JD; Efstratiadis A; Nef S Sex Dev; 2009; 3(5):264-72. PubMed ID: 19851056 [TBL] [Abstract][Full Text] [Related]
9. Inceptor counteracts insulin signalling in β-cells to control glycaemia. Ansarullah ; Jain C; Far FF; Homberg S; Wißmiller K; von Hahn FG; Raducanu A; Schirge S; Sterr M; Bilekova S; Siehler J; Wiener J; Oppenländer L; Morshedi A; Bastidas-Ponce A; Collden G; Irmler M; Beckers J; Feuchtinger A; Grzybek M; Ahlbrecht C; Feederle R; Plettenburg O; Müller TD; Meier M; Tschöp MH; Coskun Ü; Lickert H Nature; 2021 Feb; 590(7845):326-331. PubMed ID: 33505018 [TBL] [Abstract][Full Text] [Related]
10. InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma. Ma Y; Tang N; Thompson RC; Mobley BC; Clark SW; Sarkaria JN; Wang J Clin Cancer Res; 2016 Apr; 22(7):1767-76. PubMed ID: 26561558 [TBL] [Abstract][Full Text] [Related]
11. Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel. ter Braak B; Siezen CL; Kannegieter N; Koedoot E; van de Water B; van der Laan JW Arch Toxicol; 2014 Apr; 88(4):953-66. PubMed ID: 24464500 [TBL] [Abstract][Full Text] [Related]
13. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2. Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910 [TBL] [Abstract][Full Text] [Related]
14. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling. Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464 [TBL] [Abstract][Full Text] [Related]
15. Igf1R/InsR function is required for axon extension and corpus callosum formation. Jin J; Ravindran P; Di Meo D; Püschel AW PLoS One; 2019; 14(7):e0219362. PubMed ID: 31318893 [TBL] [Abstract][Full Text] [Related]
16. An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R. Fujita M; Ieguchi K; Cedano-Prieto DM; Fong A; Wilkerson C; Chen JQ; Wu M; Lo SH; Cheung AT; Wilson MD; Cardiff RD; Borowsky AD; Takada YK; Takada Y J Biol Chem; 2013 Jul; 288(27):19593-603. PubMed ID: 23696648 [TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells. Xuan S; Szabolcs M; Cinti F; Perincheri S; Accili D; Efstratiadis A J Biol Chem; 2010 Dec; 285(52):41044-50. PubMed ID: 20947509 [TBL] [Abstract][Full Text] [Related]
18. Imprinted Grb10, encoding growth factor receptor bound protein 10, regulates fetal growth independently of the insulin-like growth factor type 1 receptor (Igf1r) and insulin receptor (Insr) genes. Moorwood K; Smith FM; Garfield AS; Ward A BMC Biol; 2024 May; 22(1):127. PubMed ID: 38816743 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis. Heidegger I; Kern J; Ofer P; Klocker H; Massoner P Oncotarget; 2014 May; 5(9):2723-35. PubMed ID: 24809298 [TBL] [Abstract][Full Text] [Related]
20. Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo. Ofer P; Heidegger I; Eder IE; Schöpf B; Neuwirt H; Geley S; Klocker H; Massoner P Mol Endocrinol; 2015 Dec; 29(12):1694-707. PubMed ID: 26452103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]